Most immunosuppressant medications are designed to reduce the risk that the body will reject a transplanted organ, such as a donor kidney, liver, or heart.

Checkpoint inhibitor therapies can be thought of as the molecular “brake release” for the immune system. These drugs eliminate the protein barriers that block the immune system from ...

While the anti-aging and life-extending effects of rapamycin, developed as an immunosuppressant, are attracting attention, ...

Leflunomide is both a DMARD and an immunosuppressant. Geared toward symptoms of and long-term damage from arthritis, it is often prescribed for people who haven’t had a great response to ...

A new systematic review reveals that rapamycin – a compound originally developed as an immunosuppressant – can deliver ...

Humira is a type of immunosuppressant known as a tumor necrosis factor (TNF) inhibitor. It’s prescribed to treat autoimmune conditions. TNF is a protein that plays a key role in inflammation.

When introduced with a new immunosuppressant treatment, people with systemic lupus erythematosus (SLE) typically see clinical improvement of extrarenal flares within 6 months. A new study published in ...

“In solid organ transplantation, such as kidney transplantation, one-year outcomes are excellent because we have immunosuppressant drugs that manage the problem of acute rejection,” senior co ...

Tacrolimus outshined another immunosuppressive drug at extending relapse-free survival in kids with frequently relapsing or steroid-dependent nephrotic syndrome in a randomized study from China ...